Cuba not only prides itself on having a rate of 8.5 doctors per thousand inhabitants, one of the best in the world, but also having provided the services of 407,000 health professionals in 164 countries on all continents since 1963.
CUBA not only prides itself on having a rate of 8.5 doctors per thousand inhabitants, one of the best in the world, but also because “due to the values of solidarity and humanism that characterize us, from 1963 to the present, 407,000 health professionals have been present in 164 countries on all continents. Currently, there are more than 29,000 in 66 nations,” Cuban Public Health Minister, Dr. José Ángel Portal Miranda, recently noted on speaking at the 72nd session of the World Health Assembly, held in Geneva, Switzerland, May 20 through 28. Continue reading →
Havana, Dec 16 (Prensa Latina) Mailén Díaz Almaguer, the only survivor of the plane crash in Cuba in May that cost the lives of more than a hundred people, sent his first message of thanks to those who continued his recovery.
Through her page on the social network Facebook, the young person dedicated words of gratitude to ‘all the people who have worried … to the doctors, nurses, physiotherapists, those people who have contributed in one way or another in my recovery ‘
In the text, which immediately generated numerous comments, the girl also gave ‘many thanks to God for giving me a second chance to live and to be better every day’.
Internet surfers agreed that they were aware of its evolution in recent months and recognized the role played by ‘the medical staff and Cuban health workers who save lives not only with drugs but with love and total dedication,’ said one of the participants in the forum.
A part disseminated in local media in October explained that the young woman is assisted in a comprehensive manner by a multidisciplinary group of the Hermanos Ameijeiras Hospital, in Havana, with the participation of specialists from other institutions.
According to the report, Mailen continued the progress and took, among other procedures, the neurological rehabilitation measures and the respiratory mechanics and the healing process of soft tissue injuries.
U.S. orthopedic surgeon Xavier Duralde collaborates with Cuban doctors at Havana’s Ameijeiras Hospital.
Despite obstacles imposed by the current U.S. administration to hamper relations with Cuba, including claims of alleged “sonic attacks” against its diplomatic personnel on the island, and issuing of an unfounded travel advisory against the Caribbean nation, recommending that its population “reconsider” visiting Cuba, U.S. citizens continue wanting to experience the island and help build bridges between the two nations.
Such is the case of Dr. Xavier Duralde from the United States, experienced orthopedic surgeon and renowned professor who gave an international course on arthroscopic diagnosis and treatment of injuries to shoulder and elbow joints to Cuban colleagues at Havana’s Hermanos Ameijeiras Surgical Clinical Hospital.
A new effective conjugates vaccine against pneumococcal diseases, with seven most frequent serotypes of the pathogen, will be on market next year, leaders of the research said here today.
Developed by the Finlay Institute, the heptavalent vaccine will be registered with the name Quimi-Vio, and will reach all Cuban provinces, Dagmar García, a Research Director of the entity, told Prensa Latina.
The Forum saw the participation of 10 companies, during which representatives also discussed licensing Cuban products for the Russian market; supporting scientific projects; technology transfers; and the establishment of joint ventures between the two counties
The establishment of joint ventures in the fields of medicine and pharmaceuticals, between Russia and Cuba, directed toward strengthening beneficial trade among entities responsible for the sale and production of equipment, medicines and state-of-the-art technologies – with visible results – was just one of several issues discussed during the First Cuba-Russia Medical-Pharmaceutical Bilateral Business Forum recently held in Havana.
The event aimed to foster alliances for the development of value chains between entities in both countries; provide Russian business people with up-to-date information on Cuba’s medical-pharmaceutical sector; and identify opportunities for collaboration between research universities and institutions, technological parks and regulatory and legal frameworks.
The Forum saw the participation of 10 companies, during which representatives also discussed licensing Cuban products for the Russian market; supporting scientific projects; technology transfers; and the establishment of joint ventures between the two counties, with Russia providing the direct foreign investment for the production of medicines and pharmaceuticals on the island.
Also addressed was the establishment – under business project licenses – of Cuban-Russian medical-pharmaceutical enterprises as well as projects with academic institutions from the Eurasian country for the development of medicines.
In addition to the signing of agreements between various companies, the event also saw the identification of raw material suppliers, equipment suppliers, and service and consultation providers. There was also discussion around developing medical treatments and improving quality of life for patients in both countries.
Speaking to Granma International, Marketing Director of the Cuban state enterprise group BioCubaFarma, Mayda Maurí Pérez, noted that Russia represents a strategic partner for the entity.
“This is an extremely important event given the close level of existing relations between the two countries, and the opportunities and synergies maintained between them, above all toward strengthening the pharmaceutical sector, vital to our economic development.”
The director highlighted that there are important examples of prior bilateral efforts in the distribution of Cuban medicines registered in Russia, with good prospects of establishing a federal program, which would give Russian patients the opportunity to benefit from innovative Cuban-developed products.
“This forum has given us the chance to have the participation of the most important, advanced, and prominent Russian companies in the biopharmaceutical sector, with which we have identified interests ranging from purchases of supplies and equipment produced in Russia to bilateral agreements for products from the Cuban biopharmaceutical industry to be sold there,” she added.
Maurí also mentioned various important industry results at a national level, such as the creation of monoclonal anti-bodies to treat cancer, above all in the form of therapeutic injectables, with the potential to be produced in Russian facilities.
She went on to emphasize treatments for international patients offered by the Cuban Medical Services entity in specialized facilities on the island.